Cargando…

Securing the graft during pandemic: are we ready for cryopreservation for all?

Detalles Bibliográficos
Autores principales:	Dholaria, Bhagirathbhai, Malki, Monzr M. Al, Artz, Andrew, Savani, Bipin N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162777/ https://www.ncbi.nlm.nih.gov/pubmed/32305358 http://dx.doi.org/10.1016/j.bbmt.2020.04.009

Ejemplares similares

Overview of approved CAR‐T therapies, ongoing clinical trials, and its impact on clinical practice
por: Sengsayadeth, Salyka, et al.
Publicado: (2021)

Challenges and Advances in Chimeric Antigen Receptor Therapy for Acute Myeloid Leukemia
por: Marvin-Peek, Jennifer, et al.
Publicado: (2022)

Role of bridging therapy during chimeric antigen receptor T cell therapy
por: Bhaskar, Shakthi T., et al.
Publicado: (2021)

Cryopreservation for All Is No Option in Unrelated Stem Cell Transplantation. Comment on Dholaria B, et al. Securing the Graft During Pandemic: Are We Ready for Cryopreservation for All? Biol Blood Marrow Transplant. 2020;26:e145-e146.
por: Schmidt, Alexander H., et al.
Publicado: (2020)

Chimeric antigen receptor‐T cell therapies: The changing landscape
por: Sengsayadeth, Salyka M., et al.
Publicado: (2021)

CAR T cell therapy in solid tumors: A review of current clinical trials
por: Patel, Urvi, et al.
Publicado: (2021)

Chimeric antigen receptor T‐cell therapy: Challenges and framework of outpatient administration
por: Gatwood, Katie S., et al.
Publicado: (2021)

When a COVID-19 vaccine is ready, will we all be ready for it?
por: Fadda, Marta, et al.
Publicado: (2020)

Pandemic Influenza: Are We Ready?
por: Cinti, Sandro
Publicado: (2005)

COVID-19: should we continue to cryopreserve sperm during the pandemic?
por: Yakass, Michael Bright, et al.
Publicado: (2020)

Can We Cryopreserve the Sperm of COVID-19 Patients During the Pandemic?
por: Wu, Yongming, et al.
Publicado: (2022)

Are we ready to forget everything we have learned during the pandemic?
por: Hernández Ortiz, J.Á.
Publicado: (2022)

Responsive security: be ready to be secure
por: Kang, Meng-Chow
Publicado: (2014)

Emerging therapeutic agents for lung cancer
por: Dholaria, Bhagirathbhai, et al.
Publicado: (2016)

Balancing Quality, Cost, and Access During Delivery of Newer Cellular and Immunotherapy Treatments
por: Geethakumari, Praveen Ramakrishnan, et al.
Publicado: (2021)

The flu pandemic: were we ready?
Publicado: (2005)

Will we be judged ready for the influenza pandemic?
por: Racette, Ray J.
Publicado: (2009)

An overview of digital readiness in dentistry - are we ready?
por: Dickenson, Andrew, et al.
Publicado: (2022)

Nuclear Medicine in India: Are We Pandemic Ready?
por: Puranik, Ameya D
Publicado: (2020)

Future pandemics: how can we be ready?
por: TÜRE, Zeynep, et al.
Publicado: (2022)

Are we ready for the next pandemic? Lessons learned from healthcare professionals’ perspectives during the COVID-19 pandemic
por: Alsaeed, Dalal, et al.
Publicado: (2023)

Clinical impact of cryopreservation of allogeneic hematopoietic cell grafts during the onset of the COVID-19 pandemic
por: Devine, Steven M., et al.
Publicado: (2023)

Assay-ready Cryopreserved Cell Monolayers Enabled by Macromolecular Cryoprotectants
por: Tomás, Ruben M. F., et al.
Publicado: (2022)

Are we ready?()
por: Pedrosa, C.
Publicado: (2020)

Are we ready to deal with a global COVID-19 pandemic? Rethinking countries’ capacity based on the Global Health Security Index
por: Ji, Ye, et al.
Publicado: (2021)

Cryopreservation of Allogeneic Hematopoietic Cell Products During COVID-19 Pandemic: Graft Characterization and Engraftment Outcomes
por: Keyzner, Alla, et al.
Publicado: (2023)

Are We Ready to Offer Endovascular Thrombectomy to All Patients With Large Ischemic Core?
por: Pillai Perianen, Presaad, et al.
Publicado: (2022)

Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia
por: Dholaria, Bhagirathbhai, et al.
Publicado: (2021)

The digital era and the psychiatric follow up during COVID-19 pandemic– are we ready?
por: Andrade, G., et al.
Publicado: (2021)

Real-World Experience of Cryopreserved Allogeneic Hematopoietic Grafts during the COVID-19 Pandemic: A Single-Center Report
por: Bankova, Andriyana K., et al.
Publicado: (2022)

Are We Ready for Anything?
por: Neal-Boylan, Leslie
Publicado: (2020)

Are We Ready for Migrastatics?
por: Solomon, Jonathan, et al.
Publicado: (2021)

We are Ready for 2024!
Publicado: (2023)

The Next Influenza Pandemic: Will we be Ready to Care for Our Children?
por: Woods, Charles R., et al.
Publicado: (2005)

Haploidentical hematopoietic cell transplant recipient presents with late‐onset Epstein Barr virus‐associated posttransplant lymphoproliferative disorder
por: Braun, Adam, et al.
Publicado: (2023)

Cryopreservation of single-sperm: where are we today?
por: Liu, Shasha, et al.
Publicado: (2020)

Cancer immunotherapy beyond immune checkpoint inhibitors
por: Marin-Acevedo, Julian A., et al.
Publicado: (2018)

Pandemic influenza preparedness in the WHO African region: are we ready yet?
por: Sambala, Evanson Z., et al.
Publicado: (2018)

The impact of COVID-19 pandemic on ophthalmology services: are we ready for the aftermath?
por: Ting, Darren Shu Jeng, et al.
Publicado: (2020)

Are we ready for hotel robots after the pandemic? A profile analysis
por: Binesh, Fatemeh, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9tkehlis82us9li6lvf1efjdof